GlassScriptPhysician profile
Craig E Berger
NPI 1023031788
$17,038.43
in general payments reported to CMS, 2019-2025
33 companies · $2,843 in 2025
The $2,843 reported for 2025 was more than what 91% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,063 · 2020: $692 · 2021: $1,115 · 2022: $1,132 · 2023: $5,534 · 2024: $1,659 · 2025: $2,843.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,162 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,000 · Consulting Fee: $835 · Honoraria: $38.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,162.19 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,000.00 |
| Consulting Fee | $835.00 |
| Honoraria | $38.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $6,548.44 | 2020-2025 | Kxl System (Not Refurbished), Photrexa Viscous and Photrexa, Ce-Marked Kxla System |
| Avedro INC. | $2,450.00 | 2019 | |
| Alcon Vision LLC | $1,298.54 | 2019-2025 | Clareon, Tryptyr, Acrysof Iq Vivity |
| Bausch & Lomb Americas INC. | $1,045.25 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $690.29 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $584.71 | 2021-2025 | Acthar |
| Johnson & Johnson Surgical Vision, INC. | $491.76 | 2019-2023 | Tecnis Iol |
| Sun Pharmaceutical Industries INC. | $455.46 | 2019-2025 | Cequa |
| Oyster Point Pharma, INC. | $429.20 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Abbvie INC. | $376.24 | 2022-2024 | Durysta |
| Novartis Pharmaceuticals Corporation | $366.38 | 2019-2023 | |
| Dompe US, INC. | $297.55 | 2019-2025 | Oxervate |
| Allergan, INC. | $285.12 | 2019-2021 | |
| Rxsight INC | $261.23 | 2022-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Kala Pharmaceuticals, INC. | $232.50 | 2019-2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $216.38 | 2024-2025 | Xdemvy |
| Aerie Pharmaceuticals, INC. | $198.12 | 2019-2021 | |
| Ani Pharmaceuticals, INC. | $145.99 | 2023-2025 | Purified Cortrophin Gel |
| Shire North American Group INC | $103.31 | 2019 | |
| Harrow Eye, LLC | $73.93 | 2024-2025 | Vevye, Iheezo |
| Carl Zeiss Meditec, INC. | $64.71 | 2019 | |
| Amgen INC. | $62.76 | 2024-2025 | Tepezza |
| Sight Sciences, INC. | $49.75 | 2021-2025 | Tearcare System, Sion Surgical Instrument, Omni Surgical System |
| Biotissue Holdings INC. | $47.79 | 2019-2025 | |
| Ziemer USA | $45.57 | 2025 | Femto Ldv, Femtoldv |
| New World Medical,INC. | $41.14 | 2021-2024 | Ahmed Glaucoma Valve, Kahook Dual Blade, Streamline |
| Lombart Brothers, INC. | $40.59 | 2025 | Opd-III |
| Abb Con-Cise Optical Group LLC | $35.78 | 2019 | |
| Rayner Intraocular Lenses Limited | $28.13 | 2025 | Omidria |
| Ocular Therapeutix, INC. | $20.95 | 2022 | |
| Eyevance Pharmaceuticals LLC | $20.00 | 2019 | |
| Akorn Operating Company LLC | $17.30 | 2021 | |
| Alcon Research LLC | $13.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Berger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.